(Q54630049)

1 June 2018

title

Anti-interleukin-6 receptor antibody inhibits the progression in human colon carcinoma cells. (English)

1 reference

1 June 2018

0 references

1 reference

1 reference

Chih-Ping Hsu

1

1 reference

1 June 2018

Yung-Liang Chen

2

1 reference

1 June 2018

Chiu-Chen Huang

3

1 reference

1 June 2018

Chih-Chung Chou

4

1 reference

1 June 2018

Chia-Ling Liu

5

1 reference

1 June 2018

Chih-Hung Hung

6

1 reference

1 June 2018

Ting-Yu Kao

7

1 reference

1 June 2018

Yuan-Chiang Chung

8

1 reference

1 June 2018

publication date

26 November 2010

1 reference

1 June 2018

European Journal of Clinical Investigation

published in

1 reference

1 June 2018

volume

41

1 reference

1 June 2018

issue

3

1 reference

1 June 2018

page(s)

277-284

1 reference

1 June 2018

IL-6 in autoimmune disease and chronic inflammatory proliferative disease

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02405.X

Inflammatory cytokines and postmyocardial infarction remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02405.X

Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02405.X

Cytokine signaling in 2002: new surprises in the Jak/Stat pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02405.X

Principles of interleukin (IL)-6-type cytokine signalling and its regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02405.X

A novel peptide specifically binding to interleukin-6 receptor (gp80) inhibits angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02405.X

An unexpected biochemical and functional interaction between gp130 and the EGF receptor family in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02405.X

Interleukin-6 increases vascular endothelial growth factor and angiogenesis in gastric carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02405.X

The prognostic significance of plasma interleukin-6 levels in patients with metastatic hormone-refractory prostate cancer: results from cancer and leukemia group B 9480.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02405.X

Serum interleukin-6 levels in colorectal cancer patients--a summary of published results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02405.X

The effect of Longan seed polyphenols on colorectal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02405.X

Interleukin-6 stimulates clonogenic growth of primary and metastatic human colon carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02405.X

Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02405.X

Signaling molecules: the pathogenic role of the IL-6/STAT-3 trans signaling pathway in intestinal inflammation and in colonic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02405.X

Cytokines: from gut inflammation to colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02405.X

Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02405.X

Growth factors regulate cell survival by controlling nutrient transporter expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02405.X

Targeting the oncogenic protein kinase Ciota signalling pathway for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02405.X

Involvement of the PI 3-kinase signaling pathway in progression of colon adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02405.X

Constitutive activation of JAK3/STAT3 in colon carcinoma tumors and cell lines: inhibition of JAK3/STAT3 signaling induces apoptosis and cell cycle arrest of colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02405.X

Interleukin-6 involvement in brain arteriovenous malformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02405.X

Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02405.X

10.1111/J.1365-2362.2010.02405.X

21 January 2018

Identifiers

DOI

1 reference

1 June 2018

PubMed ID

21114487

1 reference

1 June 2018